MOSAIC CO
For the period ended Dec 31, 2024. Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 3, 2025
MOS$22.99+1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Cash Flows from Operating Activities | |||
| Net earnings including noncontrolling interests | $202.0 | $1,209.2 | $3,614.2 |
| Adjustments to reconcile net earnings including noncontrolling interests to net cash provided by operating activities: | |||
| Depreciation, depletion and amortization | 1,025.5 | 960.6 | 933.9 |
| Deferred and other income taxes | (142.9) | (261.2) | 344.4 |
| Equity in net (earnings) of nonconsolidated companies, net of dividends | (55.7) | (31.8) | (191.5) |
| Accretion expense for asset retirement obligations | 111.2 | 96.1 | 81.6 |
| Amortization of debt financing fees | 36.5 | 21.4 | 7.2 |
| Share-based compensation expense | 31.8 | 33.0 | 27.9 |
| Unrealized (gain) loss on derivatives | 104.1 | (29.0) | 4.3 |
| Foreign currency adjustments | 462.7 | (94.0) | (67.9) |
| (Gain) loss on sale of securities | (2.4) | 19.4 | 46.6 |
| Pension settlement loss | — | 42.4 | 41.9 |
| Gain on sale of business | — | (56.5) | — |
| Gain on sale of equity investment | (538.2) | — | — |
| Unrealized (gain) loss on equity securities | (28.3) | — | — |
| Other | 71.8 | 95.9 | 85.7 |
| Changes in assets and liabilities: | |||
| Receivables, net | 59.2 | 526.3 | (215.2) |
| Inventories, net | (275.6) | 1,061.4 | (749.6) |
| Other current assets and noncurrent assets | (79.2) | (239.2) | (247.4) |
| Accounts payable and accrued liabilities | 96.4 | (1,055.1) | 219.8 |
| Other noncurrent liabilities | 220.3 | 108.3 | (0.1) |
| Net cash provided by operating activities | 1,299.2 | 2,407.2 | 3,935.8 |
| Cash Flows from Investing Activities | |||
| Capital expenditures | (1,251.8) | (1,402.4) | (1,247.3) |
| Purchases of available-for-sale securities - restricted | (1,529.7) | (1,240.8) | (762.5) |
| Proceeds from sale of available-for-sale securities - restricted | 1,501.1 | 1,209.1 | 743.0 |
| Proceeds from sale of business | — | 158.4 | — |
| Acquisition of business | — | (41.0) | — |
| Other | 19.4 | (0.5) | 7.2 |
| Net cash used in investing activities | (1,261.0) | (1,317.2) | (1,259.6) |
| Cash Flows from Financing Activities | |||
| Payments of short-term debt | (16,779.6) | (9,832.0) | (1,761.2) |
| Proceeds from issuance of short-term debt | 17,032.8 | 10,007.1 | 1,980.5 |
| Payments from inventory financing arrangement | (1,805.0) | (601.4) | (1,651.5) |
| Proceeds from inventory financing arrangement | 2,004.5 | 601.4 | 1,348.8 |
| Payments of structured accounts payable arrangements | (755.0) | (1,432.9) | (1,476.6) |
| Proceeds from structured accounts payable arrangements | 737.3 | 1,048.2 | 1,460.5 |
| Collections of transferred receivables | 425.5 | 1,468.6 | 2,352.1 |
| Payments of transferred receivables | (425.5) | (1,468.6) | (2,433.2) |
| Payments of long-term debt | (67.2) | (995.3) | (610.3) |
| Proceeds from issuance of long-term debt | 70.3 | 900.0 | — |
| Repurchases of stock | (235.4) | (756.0) | (1,665.2) |
| Cash dividends paid | (270.7) | (351.6) | (197.7) |
| Dividends paid to non-controlling interest | (31.9) | (41.5) | (38.0) |
| Other | (32.0) | (26.5) | 13.1 |
| Net cash used in financing activities | (131.9) | (1,480.5) | (2,678.7) |
| Effect of exchange rate changes on cash | 37.9 | (2.8) | (29.7) |
| Net change in cash, cash equivalents and restricted cash | (55.8) | (393.3) | (32.2) |
| Cash, cash equivalents and restricted cash—beginning of year | 360.8 | 754.1 | 786.3 |
| Cash, cash equivalents and restricted cash—end of year | $305.0 | $360.8 | $754.1 |
F- 37
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets to the consolidated statements of cash flows: | |||
| Cash and cash equivalents | $272.8 | $348.8 | $735.4 |
| Restricted cash in other current assets | 14.9 | 8.6 | 8.2 |
| Restricted cash in other assets | 17.3 | 3.4 | 10.5 |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows | $305.0 | $360.8 | $754.1 |
F- 38
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.